Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jyothi S et al. – There is sufficient scientific and statistical evidence to advocate the effective use of OCT–guided administration of intravitreal bevacizumab for neovascular AMD. This is reflected in this study outcome measures that are comparable to findings published from recent well–conducted RCTs on intravitreal ranibizumab at the same time point.

Today in Clinical Pharmacology...keeping you current

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis
International Ophthalmology, 12/16/09

Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Today in Retina...keeping you current

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis
International Ophthalmology, 12/16/09

Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address